Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
aTyr Pharma (DE:471A)
FRANKFURT:471A
Holding DE:471A?
Track your performance easily
471A Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.99 - €2.32
Previous Close€1.51
Volume0.00
Average Volume (3M)2.06K
Market Cap
€117.03M
Enterprise Value€58.69M
Total Cash (Recent Filing)$78.48M
Total Debt (Recent Filing)$13.85M
Price to Earnings (P/E)―
Beta0.90
Next Earnings
Nov 07, 2024EPS Estimate
-€0.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding75,796,198
10 Day Avg. Volume0
30 Day Avg. Volume2,056
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)1.40
Price to Sales (P/S)224.29
Price to Cash Flow (P/CF)-1.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue99.81
Enterprise Value/Gross Profit166.25
Enterprise Value/Ebitda-1.01
Forecast
1Y Price Target
€18.40Price Target Upside1118.74% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
aTyr Pharma News
Options Prices
Currently, No data available
---
Ownership Overview
2.67% Insiders
32.31% Mutual Funds
22.36% Other Institutional Investors
42.66% Public Companies and
Individual Investors
471A FAQ
What was aTyr Pharma’s price range in the past 12 months?
aTyr Pharma lowest stock price was €0.98 and its highest was €2.32 in the past 12 months.
What is aTyr Pharma’s market cap?
Currently, no data Available
When is aTyr Pharma’s upcoming earnings report date?
aTyr Pharma’s upcoming earnings report date is Nov 07, 2024 which is in 42 days.
How were aTyr Pharma’s earnings last quarter?
aTyr Pharma released its earnings results on Aug 13, 2024. The company reported -€0.207 earnings per share for the quarter, beating the consensus estimate of -€0.228 by €0.021.
Is aTyr Pharma overvalued?
According to Wall Street analysts aTyr Pharma’s price is currently Undervalued.
Does aTyr Pharma pay dividends?
aTyr Pharma does not currently pay dividends.
What is aTyr Pharma’s EPS estimate?
aTyr Pharma’s EPS estimate is -€0.2.
How many shares outstanding does aTyr Pharma have?
aTyr Pharma has 75,796,196 shares outstanding.
What happened to aTyr Pharma’s price movement after its last earnings report?
aTyr Pharma reported an EPS of -€0.207 in its last earnings report, beating expectations of -€0.228. Following the earnings report the stock price went down -4.321%.
Which hedge fund is a major shareholder of aTyr Pharma?
Among the largest hedge funds holding aTyr Pharma’s share is Woodline Partners LP. It holds aTyr Pharma’s shares valued at 3M.
---
aTyr Pharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€18.40 (1118.74% Upside)
€18.40 (1118.74% Upside)
Blogger Sentiment
Bullish
DE:471A Sentiment 100%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth $184.4K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
10.96%
12-Months-Change
Fundamentals
Return on Equity
-61.64%
Trailing 12-Months
Asset Growth
-20.19%
Trailing 12-Months
Company Description
aTyr Pharma
aTyr Pharma, Inc. develops protein therapeutics and novel class of biologic drugs. It plans to build a pipeline of therapeutic products based on Physiocrine biology. The company has established a dominant intellectual property estate to protect the core therapeutics as well as associated diagnostics. aTyr Pharma was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.
---
471A Earnings Call
Q4 2024
0:00 / 0:00
---
471A Stock 12 Month Forecast
Average Price Target
€18.40
▲(1118.74% Upside)
Technical Analysis
aTyr Pharma
―
AnaptysBio
―
Crinetics Pharmaceuticals
―
Fate Therapeutics
―
Mersana Therapeutics
―
Best Analysts Covering 471A
1 Year
1 Year Success Rate
4/11 ratings generated profit
1 Year Average Return
+5.85%
reiterated a buy rating last month
Copying Joseph Pantginis's trades and holding each position for 1 Year would result in 36.36% of your transactions generating a profit, with an average return of +5.85% per trade.
---